Resources
75 Results (showing 61 - 70)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 3/21/2023 (updated 3/27/2024)
Researchers at Indiana University conducted one-on-one interviews with clinical providers and other stakeholders in the recovery arena to better understand the slow uptake of the drug most used to treat opioid use disorder. Biases against buprenorphine was the most consistent theme, though the reason for bias differed amongst stakeholders. Clinical providers and behavioral health care providers preferred the abstinence approach rather than use of medications.
Posted 9/25/2023 (updated 3/27/2024)
The Substance Abuse and Mental Health Services Administration (SAMHSA) now has the "Engaging Community Coalitions to Decrease Opioid Overdose Deaths Practice Guide" available, as a product of the HEALing Communities Study (HCS).
Posted 7/6/2022 (updated 3/27/2024)
This paper illustrates survival models for analysis of trials of substance use treatment programs. It uses public release data from a study of extended-release naltrexone (XR-NTX), relative to buprenorphine-naloxone (BUP-NX).
Posted 3/23/2022 (updated 3/27/2024)
Over the past 20 years, drug overdose deaths have increased dramatically in the United States. Most of these deaths involved opioids, including prescription pain medications, heroin, and synthetic opioids such as fentanyl. These are called opioid-related overdoses and often occur as a result of respiratory depression caused by opioids, even when other medications and drugs are involved.
Posted 3/22/2022 (updated 3/27/2024)
The purpose of this document is to provide detailed guidelines of the Nurse Care Manager Model of Office Based Addiction Treatment program for management of substance use disorders, with particular emphasis on treatment of opioid use disorder with buprenorphine (alone and in combination with naloxone) and naltrexone (oral and extended-release injectable formulations).
Posted 6/10/2022 (updated 3/27/2024)
More people are dying from overdose now than at any point in history. Individuals learned about three innovative communication campaigns that challenge stigma, center people who use drugs, and build support for harm reduction as a lifesaving strategy to reduce overdose deaths.
Posted 6/8/2022 (updated 3/27/2024)
A collaborative community process to define a town by what it offers the people who live there is the short way to describe the work of placemaking. This digital toolkit from the U.S. Department of Agriculture and the University of Kentucky’s Community and Economic Development Initiative includes examples of rural placemaking projects along with technical assistance providers, funders, and guides to resources.
Posted 3/15/2022 (updated 3/27/2024)
This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support people in recovery.
Posted 9/8/2023 (updated 3/26/2024)
September 2023 is National Recovery Month and HRSA’s Office of Women’s Health has a toolkit to support organizations and health care providers that care for women living with opioid use disorder (OUD). The toolkit provides strategies to engage women with OUD, care coordination for support, and other resources.
Posted 8/8/2023 (updated 3/26/2024)
This webinar is an invaluable opportunity for health care professionals, policymakers, researchers, and anyone else interested in mental health and substance use interventions to learn about the latest research and innovative approaches in the field.